300+ National & State Organizations Ask Congress: Stop the CMS Drug Payment Proposal!
This morning an unprecedented 316 national and state healthcare and related organizations sent a letter to Congress expressing strong concern with the proposedCMS Medicare Part B Drug Payment Model. The organizations request that Congress ask CMS to withdraw the proposed rule.
The letter notes that the organizations believe that “this type of initiative, implemented without sufficient stakeholder input, will adversely affect the care and treatment of Medicare patients with complex conditions, such as cancer, macular degeneration, hypertension, rheumatoid arthritis, Crohn’s disease and ulcerative colitis, and primary immunodeficiency diseases.”
The letter follows an outpouring of concern and opposition to the proposed CMS Medicare Part B Drug Payment Model, including three previous letters sent this month from 1) COA, 2) more than 60 allied cancer organizations, and 3) more than 100 organizations representing patients, providers, advocates, and others.
COA believes that the proposed CMS Medicare Part B Drug Payment Model is a misguided and perilous experiment that will have a significant impact on the cancer care America’s seniors receive. It sets a dangerous precedent of having policymakers dictate what cancer care is acceptable instead of practicing oncologists in collaboration with their patients.
Continue Reading on CommunityOncology.org to read the latest letter.
